Transbiotech
- Company typePrivate
- Founded1999
- HeadquartersLévis, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
Transbiotech firmographics
Firmographics- Name
- Transbiotech
- Legal name
- TransBIOTech
- Website
- https://transbio.tech
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Transbiotech industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)
- akta.pro secondary industries
- Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC), Translational Medicine & Biomarkers (HLAIALAF)
Keywords
Where Transbiotech is headquartered
LocationHeadquarters
- HQ city
- Lévis
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Transbiotech business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Research and Development Services: Project-based preclinical research services including bioanalysis, cellular assays, animal models, and custom development for biotech, pharmaceutical, cosmetics, and natural health products companies. Revenue generated through service contracts with private sector and academic partners.
- Financial Support Facilitation: As a CCTT (College Technology Transfer Center), Transbiotech helps clients access government funding programs including RDA, PARI, PART, FRQ, and tax credits up to 80% of billable costs
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom Project-Based Pricing |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels5 records
Transbiotech product offering
Product offeringCore offering
Transbiotech provides preclinical contract research services to biotech, pharmaceutical, cosmetics, and natural health products companies. The organization delivers in vitro cell assays, in vivo animal model studies in a CCPA-accredited facility, preclinical bioanalysis using chromatography and mass spectrometry, and custom method development. It also facilitates access to government R&D funding programs covering up to 80% of project costs through its CCTT (Centre Collégial de Transfert de Technologie) status.
Product overview
Transbiotech is a non-profit biotechnology research organization (CCTT - Centre Collégial de Transfert de Technologie) affiliated with Cégep de Lévis, Quebec, providing preclinical contract research services since 1999. The company offers an integrated portfolio of laboratory services including: Cell Assays (in vitro cell and biochemical testing), Preclinical Bioanalysis (chromatography and mass spectrometry), Animal Models (in vivo pharmacology in CCPA-accredited facility), Custom Development (tailored assay development), and Financial Support (R&D funding assistance). These core services are organized around six scientific expertise areas: Cell Biology, Analytical Chemistry, Immunology, Inflammation, Microbiology, and Pharmacology. The company serves the pharmaceutical, cosmetic, and natural health products sectors. Key laboratory equipment installations include analytical/bioanalytical laboratories with mass spectrometry systems (TQD, TQS, TQS-micro), the IncuCyte S3 real-time imaging system, SAPPHIRE biomolecular imager, Pannoramic MIDI II slide scanner, LSRFortessa X-20 flow cytometer, IVIS Lumina XR animal imaging system, and BugBox anaerobic chamber.
Differentiator
Problem solved
Functional benefit
Products and services
- Cell Assays (Essais cellulaires) In cellulo and in vitro cell and biochemical assays performed on cell lines, primary cells, spheroids, and reconstructed human tissues for evaluating biological efficacy, toxicity, and biomarker detection. Serves biotech, pharmaceutical, cosmetics, and natural health products companies.
- Preclinical Bioanalysis (Bioanalyse préclinique) Preclinical bioanalytical services for quantifying metabolites in various matrices (plasma, urine, tissues) using chromatography and mass spectrometry equipment. Supports pharmacokinetics, ADME, and biodistribution studies for drug development clients.
- Animal Models (Modèles animaux) In vivo pharmacology studies using validated preclinical models for inflammatory diseases, pulmonary inflammation, fibrosis, joint pain, oncology, neurodegenerative diseases, metabolic disorders, skin diseases, and pharmacokinetics/toxicology studies in a CCPA-accredited animal facility.
- Custom Development (Développement sur mesure) Custom assay and method development tailored to specific client project requirements, including custom biochemical or cellular assay development for novel research applications.
- Financial Support (Soutien financier) Assistance in obtaining funding for R&D projects through various government programs including RDA, PARI, PART, FRQ, and tax credits covering up to 80% of billable costs. Helps clients access Canadian federal and provincial research funding.
Quantifiable outcome
- 100+ research projects completed annually with 50+ partners
- +2 more outcomes
Companies that use Transbiotech
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles3 records
Transbiotech technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
Transbiotech partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- Feldan ThérapeutiquescoreThree-year collaboration on intralesional tumor treatment development funded by $450,000 NSERC research grant. Transbiotech conducts in vivo experiments for Feldan's therapeutic candidates. Partnership builds on nearly 10 years of collaboration supporting Feldan's intracellular delivery platform.
- Cégep de LéviscoreParent institution and affiliated CCTT. Provides institutional framework, student integration, and research infrastructure. Cégep de Lévis ranked 18th among Canada's Top 50 Research Colleges 2025.
- BienaminorCollaboration awarded $300,000 grant to advance population health and microbiome-based innovation research.
- BioQuebecminorMember of Quebec biotechnology industry association for networking and industry advocacy.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Transbiotech competitors and assessment
Company assessmentDirect peers
- Altasciences: Canadian preclinical and clinical CRO headquartered in Laval, Quebec, offering integrated drug development services from preclinical through Phase I/IIa. Highly comparable to Transbiotech given shared Quebec base, preclinical service focus, and biotech/pharma client base, though Altasciences operates at significantly larger scale and across clinical phases.
- Celerion: Early-phase CRO specializing in clinical pharmacology and bioanalytical services with strong preclinical support capabilities. Comparable to Transbiotech's bioanalysis and preclinical pharmacology offerings, particularly for small-molecule and biologics sponsors requiring PK/PD expertise.
- Inotiv: Preclinical CRO and research models provider specializing in animal model studies, toxicology, and safety assessment. Comparable to Transbiotech's CCPA-accredited in vivo pharmacology and toxicology services, though Inotiv operates primarily in U.S. and European markets.
- Biotrial: European-based preclinical and early clinical CRO offering integrated drug development services. Comparable to Transbiotech's preclinical CRO capabilities including pharmacology, safety assessment, and bioanalysis, though Biotrial has stronger clinical phase capabilities.
Broad incumbents
- Charles River Laboratories: Global CRO with extensive preclinical services including animal models, safety assessment, and bioanalysis. Directly comparable to Transbiotech's core offerings of in vivo pharmacology and bioanalytical services, but operates at massive global scale with much broader therapeutic area coverage.
- WuXi AppTec: Global CRO/CDMO providing comprehensive preclinical, clinical, and bioanalytical services. Overlaps significantly with Transbiotech's preclinical CRO offerings but operates at vastly larger scale with global footprint and integrated drug development platform.
- Eurofins Scientific: Global bioanalytical and preclinical testing services provider with extensive laboratory network. Comparable to Transbiotech's bioanalytical chemistry capabilities and preclinical testing services, though Eurofins operates globally with much broader service portfolio.
- Labcorp Drug Development: Major global CRO (formerly Covance) offering preclinical, clinical, and central laboratory services. Directly comparable to Transbiotech's preclinical CRO and bioanalytical offerings, but at much larger scale with extensive therapeutic area and global reach.
- ICON plc: Global CRO providing clinical, bioanalytical, and preclinical research services. Comparable to Transbiotech's bioanalytical and preclinical offerings, though ICON's primary focus is on clinical trials and operates at significantly larger scale.
- SGS (Life Sciences): Global testing, inspection, and certification company with life sciences division offering preclinical and bioanalytical services. Comparable to Transbiotech's bioanalytical chemistry and preclinical testing capabilities, though SGS operates much broader portfolio across multiple industries.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Transbiotech social profiles
Digital presenceTransbiotech compliance and trust
Trust signalCompliance2 records
Transbiotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Transbiotech leadership team
Management profileNumber of profiles
Profiles7 records
Transbiotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Transbiotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Transbiotech
What does Transbiotech do?
Transbiotech provides preclinical contract research services to biotech, pharmaceutical, cosmetics, and natural health products companies. The organization delivers in vitro cell assays, in vivo animal model studies in a CCPA-accredited facility, preclinical bioanalysis using chromatography and mass spectrometry, and custom method development. It also facilitates access to government R&D funding programs covering up to 80% of project costs through its CCTT (Centre Collégial de Transfert de Technologie) status.
Is Transbiotech a public or private company?
Transbiotech is a private company. It is classified as state government owned and is currently operating.
When was Transbiotech founded?
Transbiotech was founded in 1999. It employs 11 to 50 people.
Where is Transbiotech based?
Transbiotech is headquartered in Lévis, Canada, in the North America region.
How does Transbiotech make money?
Two revenue lines are on record. Research and Development Services are the primary driver. The others are financial Support Facilitation.
Who are Transbiotech's main competitors?
Direct peers on record are Altasciences, Celerion, Inotiv and Biotrial. Broad incumbents are Charles River Laboratories, WuXi AppTec, Eurofins Scientific, Labcorp Drug Development, ICON plc and SGS (Life Sciences).
Does Transbiotech have an API?
No public API is recorded for Transbiotech.
What industry is Transbiotech in?
Transbiotech's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAGAAAC, Toxicology & Safety Assessment CROs (GLP). Its NAICS code is 5417 and its SIC code is 8731.